Peptuno
Other Research Peptides

Product details

Botulinum Toxin Type A is a ~150 kDa zinc-metalloprotease neurotoxin produced by Clostridium botulinum and, by mass, among the most potent biological toxins characterized. Its heavy chain mediates uptake at motor-neuron presynaptic terminals and its light chain cleaves SNAP-25, a SNARE protein required for acetylcholine vesicle docking. It is referenced here strictly as a characterized regulated biological for qualified research contexts — not described for any therapeutic or aesthetic outcome, and not supplied for human administration.

This is the most strongly regulated item in the catalogue. Peptuno makes Botulinum Toxin Type A available only to qualified buyers with explicit import authorization, select-agent / controlled-biological licensing, and chain-of-custody documentation appropriate to their destination jurisdiction; orders require full compliance review — end-user declaration, intended-use specification, and storage / handling confirmation — prior to acceptance, with controlled cold-chain logistics and temperature monitoring on shipment. The material is supplied as the lyophilized 150 kDa complex stabilized with human serum albumin in the standard 100 IU vial format; potency is expressed by bioassay (IU) rather than chromatographic purity alone, since complex integrity governs activity. Sold for Research Use Only.

Regulatory note: Heavily regulated neurotoxin classified as a select agent in the US and under analogous controlled-biological frameworks worldwide. Sold for Research Use Only and only to qualified buyers with appropriate select-agent / controlled-biological licensing, import authorization, and chain-of-custody documentation in their jurisdiction. Order requires full compliance review prior to acceptance; not a finished dosage form and not labelled for human administration.

FAQ

Why is Botulinum Toxin classified as a select agent, and what does that mean for access?
It is on the HHS Select Agents and Toxins List in the US (under CDC's Federal Select Agent Program) and analogous controlled-biological lists worldwide, because it is acutely toxic at extremely low doses and carries historical bioweapon concern. In practice a buyer must demonstrate a legitimate research use case, appropriate facility security and storage controls, registered status with the national select-agent regulator, and chain-of-custody documentation throughout the lifecycle. Peptuno verifies all of these before order acceptance.
How is potency expressed for this biological, and why not chromatographic purity alone?
Potency is expressed in International Units (IU) by bioassay, because the activity of the toxin depends on the integrity of the ~150 kDa complex rather than on chromatographic purity of a small molecule. A purity figure does not, on its own, capture functional activity for a large protein toxin, so the bioassay IU value is the operative potency statement on the documentation.
What cold-chain handling does the material require?
Strict cold-chain throughout: the lyophilized material holds at 2–8 °C with only brief operational excursions, shipped in validated cold-chain packaging with continuous temperature monitoring whose record forms part of the documentation chain. A receiving facility must have validated cold-chain storage in place before delivery; Peptuno's logistics review confirms the receiving facility's cold-chain capability as part of the pre-shipment compliance check.

Certificate of Analysis (COA)

The per-lot COA for this product will appear here.